Organization Profile

You just read:

Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA™ (Daclizumab Beta) for Multiple Sclerosis

News provided by

Biogen

Dec 09, 2016, 08:00 ET